NCT07670260 GoFast CAR T-Cell Therapy for Recurrent Refractory B-Cell Lymphoma Status NOT_YET_RECRUITING Phase EARLY_PHASE1
NCT07479797 Study Evaluating the Efficacy of KITE-753 Versus Axicabtagene Ciloleucel in Participants With Relapsed or Refractory Large B-Cell Lymphoma After First-Line Therapy Status RECRUITING Phase PHASE3
NCT06788964 Loncastuximab Tesirine and Rituximab as Bridging Therapy Before Standard-of-care CAR-T Therapy in Patients With Large B-cell Lymphoma (CORAL) Status RECRUITING Phase PHASE2
NCT05459571 Study of Axicabtagene Ciloleucel Given With Steroids In Participants With Relapsed Or Refractory Large B-Cell Lymphoma Status COMPLETED Phase PHASE2